María del Pilar
Herrera Puente
Profesor/a Asociado/a en CC. de la Salud
Mutua de Terrassa
Terrassa, EspañaPublications in collaboration with researchers from Mutua de Terrassa (3)
2024
-
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial
Haematologica, Vol. 109, Núm. 2, pp. 543-552